European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma

TOKYO Japan's business-to-business service prices rose 2.1% in August from a year earlier, accelerating from a 1.7% year-on-year

By Jody Godoy NEW YORK Sam Bankman-Fried's confidant Caroline Ellison will take the stand again at the FTX

Mizuho Financial Group Inc.’s securities arm is boosting hiring in the US as it seeks to cement its

(Reuters) -Swiss bank UBS Group AG has set aside $4 billion in provisions for potential litigation and regulatory issues stemming

TORONTO Canadian economic activity contracted in July for the first time in seven months as a measure of

The NFL's Buffalo Bills and the NHL's Sabres will operate as separate entities after the teams’ owner Terry Pegula dissolved their parent company

A near-$10 trillion rally for global stocks this year will face a make-or-break moment as hundreds of companies

By Gabriel Burin Brazil likely registered mild deflation in June in monthly terms from lower fuel costs and

ROME The European Central Bank (ECB) needs to be careful not to cause "unnecessary damage" to the economy

Ports operator DP World said Sunday it had made "significant strides" towards resuming normal freight trade at major gateways into Australia, which have been crippled for...

By Krystal Hu Venture capital funding globally almost halved in the first six months of 2023, data from